Page results
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients who have been given a walking boot, including air cast boots, pneumatic walking boots and vacoped boots.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
File results
-
FOI/2024/0646 - Management of Combine Heat and Power (CHP) units
-
FOI/2024/0647 - Treatment of rare diseases; Fabry/ Gaucher/ Pompe disease
-
FOI/2024/0650 - Framework used for Radiology Information System (RIS)
-
FOI/2024/0653 - Sterile services/ decontamination units
-
FOI/2024/0664 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0661 - Maternity services for caesareans
-
FOI/2024/0666 - Non-emergency patient transport services (NEPTS) and pathology specimen courier services
-
FOI/2024/0696 - Various IT systems used at Trust
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0660 - Bariatric patient equipment spend/ contract/ supplier